🔒 Premium: BizNews TV gets YouTube Strike – over a year old Ivermectin discussion

LATEST ON BIZNEWS RADIO (on iTunes): “The industry will get away with what it can…” – Revisiting SA’s ‘out of step’ performance fees with OMBA’s Mark Perchtold. (Click here for Spotify)

Today’s newsletter was supposed to direct you at recordings of some brilliant keynotes delivered at BNC#4 last week. But that’s been delayed after we were banned from uploading fresh material after a complaint to YouTube over an Ivermectin-related video discussion we published over a year ago. Here’s the link to the audio version which you can access on Spotify.


We have always taken the view that YouTube is entitled to set its own rules on the kind of content published on its channel. So we won’t appeal the decision nor challenge the platform’s right to apply its rules as it sees fit. But we are surprised at its decision to suspend us from uploading new material until next Monday as we were unaware that our video broke any Community Guidelines. Such is life.

What the challenge does show, however, is growing desperation among the anti-Ivermectin lobby. Which is perhaps to be expected as evidence grows that this cheap, no-side-effect Nobel Prize winning drug – ridiculed by the Big Pharma and its acolytes as ‘horse medicine’ – does work against Covid-19.

Latest blow for the critics was last week’s release of a strictly controlled Brazilian study of 88 000 people that concluded regular use of Ivermectin as a prophylaxis reduced Covid mortality rates by 92%. Not the kind of thing Big Pharma, nor the WHO likes to see up in lights. But make up your own mind. Click here to access the full report.

More for you to read today: 


As a Premium subscriber you are entitled to full membership of wsj.com (normal price $29 a month). Be sure to action your access through the Premium link on the BizNews website. Because of The Wall Street Journal’s credential requirements, be sure to create a password which has at least 8 characters and includes at least one letter and one number – NB it MAY NOT contain any special characters (ie #, !, @ etc). To maintain access to WSJ.com, you MUST enter our partner’s website via Biznews Premium at least once a month. A final PS, if you had previously signed up for WSJ you’ll need to clear the cookies from your device. Our helpdesk can assist –[email protected].

Visited 104 times, 1 visit(s) today